P17809
Gene name |
Slc2a1 |
Protein name |
Solute carrier family 2, facilitated glucose transporter member 1 |
Names |
Glucose transporter type 1, erythrocyte/brain, GLUT-1, GT1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:20525 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P17809
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P17809-F1 | Predicted | AlphaFoldDB |
19 variants for P17809
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3394604496 | 137 | T>A | No | EVA | |
| rs3388705851 | 153 | R>H | No | EVA | |
| rs3388693250 | 166 | V>I | No | EVA | |
| rs3388709760 | 195 | I>T | No | EVA | |
| rs3388693260 | 203 | L>P | No | EVA | |
| rs3388693202 | 207 | C>Y | No | EVA | |
| rs3388713438 | 217 | N>S | No | EVA | |
| rs48217876 | 250 | Q>H | No | EVA | |
| rs3388702496 | 306 | P>H | No | EVA | |
| rs3388708202 | 352 | T>S | No | EVA | |
| rs3388695482 | 354 | A>T | No | EVA | |
| rs3388685592 | 357 | L>M | No | EVA | |
| rs3394758791 | 361 | L>Q | No | EVA | |
| rs3388705445 | 391 | V>M | No | EVA | |
| rs3388693226 | 446 | I>N | No | EVA | |
| rs3388713471 | 454 | E>G | No | EVA | |
| rs3388695461 | 458 | R>L | No | EVA | |
| rs3394493359 | 469 | Q>L | No | EVA | |
| rs3388708192 | 489 | D>H | No | EVA |
No associated diseases with P17809
3 regional properties for P17809
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| conserved_site | Sugar transporter, conserved site | 128 - 153 | IPR005829-1 |
| conserved_site | Sugar transporter, conserved site | 324 - 340 | IPR005829-2 |
| domain | Major facilitator superfamily domain | 15 - 456 | IPR020846 |
22 GO annotations of cellular component
| Name | Definition |
|---|---|
| apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
| basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
| caveola | A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm. |
| cell-cell junction | A cell junction that forms a connection between two or more cells of an organism; excludes direct cytoplasmic intercellular bridges, such as ring canals in insects. |
| cortical actin cytoskeleton | The portion of the actin cytoskeleton, comprising filamentous actin and associated proteins, that lies just beneath the plasma membrane. |
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| female germ cell nucleus | The nucleus of the female germ cell, a reproductive cell in females. |
| female pronucleus | The pronucleus originating from the ovum that is being fertilized. |
| Golgi membrane | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| intercalated disc | A complex cell-cell junction at which myofibrils terminate in cardiomyocytes; mediates mechanical and electrochemical integration between individual cardiomyocytes. The intercalated disc contains regions of tight mechanical attachment (fasciae adherentes and desmosomes) and electrical coupling (gap junctions) between adjacent cells. |
| membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| membrane raft | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
| midbody | A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis. |
| photoreceptor inner segment | The inner segment of a vertebrate photoreceptor containing mitochondria, ribosomes and membranes where opsin molecules are assembled and passed to be part of the outer segment discs. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| presynapse | The part of a synapse that is part of the presynaptic cell. |
| sarcolemma | The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers. |
| synapse | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. |
| vesicle | Any small, fluid-filled, spherical organelle enclosed by membrane. |
| Z disc | Platelike region of a muscle sarcomere to which the plus ends of actin filaments are attached. |
9 GO annotations of molecular function
| Name | Definition |
|---|---|
| D-glucose transmembrane transporter activity | Enables the transfer of the D-enantiomer of the hexose monosaccharide glucose from one side of a membrane to the other. |
| dehydroascorbic acid transmembrane transporter activity | Enables the transfer of dehydroascorbate, 5-(1,2-dihydroxyethyl)furan-2,3,4(5H)-trione, from one side of a membrane to the other. |
| glucose transmembrane transporter activity | Enables the transfer of the hexose monosaccharide glucose from one side of a membrane to the other. |
| hexose transmembrane transporter activity | Enables the transfer of a hexose sugar, a monosaccharide with 6 carbon atoms, from one side of a membrane to the other. |
| identical protein binding | Binding to an identical protein or proteins. |
| kinase binding | Binding to a kinase, any enzyme that catalyzes the transfer of a phosphate group. |
| long-chain fatty acid transporter activity | Enables the transfer of long-chain fatty acids from one side of a membrane to the other. A long-chain fatty acid is a fatty acid with a chain length between C13 and C22. |
| protein self-association | Binding to a domain within the same polypeptide. |
| xenobiotic transmembrane transporter activity | Enables the directed movement of a xenobiotic from one side of a membrane to the other. A xenobiotic is a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
19 GO annotations of biological process
| Name | Definition |
|---|---|
| cellular hyperosmotic response | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hyperosmotic environment, i.e. an environment with a higher concentration of solutes than the organism or cell. |
| cellular response to glucose starvation | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of glucose. |
| cellular response to mechanical stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| central nervous system development | The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord. |
| cerebral cortex development | The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon. |
| dehydroascorbic acid transport | The directed movement of dehydroascorbate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Dehydroascorbate, 5-(1,2-dihydroxyethyl)furan-2,3,4(5H)-trione, is an oxidized form of vitamin C. |
| female pregnancy | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
| glucose import | The directed movement of the hexose monosaccharide glucose into a cell or organelle. |
| glucose import across plasma membrane | The directed movement of glucose from outside of a cell, across the plasma membrane and into the cytosol. |
| glucose transmembrane transport | The process in which glucose is transported across a membrane. |
| long-chain fatty acid import across plasma membrane | The directed movement of long-chain fatty acids from outside of a cell, across the plasma membrane and into the cytosol. A long-chain fatty acid is a fatty acid with a chain length between C13 and C22. |
| monosaccharide transmembrane transport | The process in which a monosaccharide is transported across a lipid bilayer, from one side of a membrane to the other. Monosaccharides are the simplest carbohydrates; they are polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides. |
| photoreceptor cell maintenance | Any process preventing the degeneration of the photoreceptor, a specialized cell type that is sensitive to light. |
| protein-containing complex assembly | The aggregation, arrangement and bonding together of a set of macromolecules to form a protein-containing complex. |
| response to hypoxia | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| response to insulin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
| response to Thyroglobulin triiodothyronine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a Thyroglobulin triiodothyronine stimulus. |
| transport across blood-brain barrier | The directed movement of substances (e.g. macromolecules, small molecules, ions) through the blood-brain barrier. |
| xenobiotic transport | The directed movement of a xenobiotic into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A xenobiotic is a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
4 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P58352 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Bos taurus (Bovine) | PR |
| P27674 | SLC2A1 | Solute carrier family 2, facilitated glucose transporter member 1 | Bos taurus (Bovine) | PR |
| P11166 | SLC2A1 | Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (Human) | PR |
| P20303 | SLC2A1 | Solute carrier family 2, facilitated glucose transporter member 1 | Sus scrofa (Pig) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDPSSKKVTG | RLMLAVGGAV | LGSLQFGYNT | GVINAPQKVI | EEFYNQTWNH | RYGEPIPSTT |
| 70 | 80 | 90 | 100 | 110 | 120 |
| LTTLWSLSVA | IFSVGGMIGS | FSVGLFVNRF | GRRNSMLMMN | LLAFVAAVLM | GFSKLGKSFE |
| 130 | 140 | 150 | 160 | 170 | 180 |
| MLILGRFIIG | VYCGLTTGFV | PMYVGEVSPT | ALRGALGTLH | QLGIVVGILI | AQVFGLDSIM |
| 190 | 200 | 210 | 220 | 230 | 240 |
| GNADLWPLLL | SVIFIPALLQ | CILLPFCPES | PRFLLINRNE | ENRAKSVLKK | LRGTADVTRD |
| 250 | 260 | 270 | 280 | 290 | 300 |
| LQEMKEEGRQ | MMREKKVTIL | ELFRSPAYRQ | PILIAVVLQL | SQQLSGINAV | FYYSTSIFEK |
| 310 | 320 | 330 | 340 | 350 | 360 |
| AGVQQPVYAT | IGSGIVNTAF | TVVSLFVVER | AGRRTLHLIG | LAGMAGCAVL | MTIALALLER |
| 370 | 380 | 390 | 400 | 410 | 420 |
| LPWMSYLSIV | AIFGFVAFFE | VGPGPIPWFI | VAELFSQGPR | PAAIAVAGFS | NWTSNFIVGM |
| 430 | 440 | 450 | 460 | 470 | 480 |
| CFQYVEQLCG | PYVFIIFTVL | LVLFFIFTYF | KVPETKGRTF | DEIASGFRQG | GASQSDKTPE |
| 490 | |||||
| ELFHPLGADS | QV |